1. Home
  2. MRCY vs XENE Comparison

MRCY vs XENE Comparison

Compare MRCY & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

HOLD

Current Price

$104.30

Market Cap

6.3B

Sector

N/A

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$62.90

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRCY
XENE
Founded
1981
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.2B
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
MRCY
XENE
Price
$104.30
$62.90
Analyst Decision
Buy
Strong Buy
Analyst Count
8
11
Target Price
$80.00
$68.55
AVG Volume (30 Days)
524.3K
599.0K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
72.69
N/A
EPS
N/A
N/A
Revenue
$912,020,000.00
$311,000.00
Revenue This Year
$6.59
N/A
Revenue Next Year
$9.56
$2,496.48
P/E Ratio
N/A
N/A
Revenue Growth
9.19
N/A
52 Week Low
$62.78
$35.60
52 Week High
$128.45
$72.66

Technical Indicators

Market Signals
Indicator
MRCY
XENE
Relative Strength Index (RSI) 50.48 46.89
Support Level $102.63 $61.16
Resistance Level $115.34 $62.91
Average True Range (ATR) 5.30 2.06
MACD 0.76 -0.41
Stochastic Oscillator 68.31 28.72

Price Performance

Historical Comparison
MRCY
XENE

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: